Obligations in a global health emergency - Authors’ reply

Lancet 398 (10316):2072 (2021)
  Copy   BIBTEX


In response to commentators, we argue that whether waiving patent rights will meaningfully improve access to COVID-19 vaccines for low income and middle-income countries (LMICs), particularly in the short term, is an empirical matter. We also reject preferentially allocating vaccines to countries that hosted trials because doing so unethically favours those with research infrastructure, rather than those facing the worst burdens from COVID-19.



External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Reassessing the VaxTax.Nathan Petrovic - 2024 - Journal of Medical Ethics 50 (4):222-225.


Added to PP

261 (#81,298)

6 months
127 (#34,305)

Historical graph of downloads
How can I increase my downloads?

Author Profiles

Govind Persad
University of Denver
Kok-Chor Tan
University of Pennsylvania
Lisa Maria Herzog
University of Groningen
2 more

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references